Home

kandidiasis

Kandidiasis is a fungal infection caused by yeasts of the genus Candida. Candida species are common inhabitants of the human microbiota, particularly in the mouth, gastrointestinal tract and vagina. Disease occurs when the yeasts overgrow or invade tissues, ranging from superficial mucosal infections to invasive, life-threatening disease. The most frequently implicated species is Candida albicans, though non-albicans species such as C. glabrata, C. tropicalis and C. parapsilosis are increasingly encountered.

Clinical forms include mucosal infections such as oropharyngeal candidiasis (thrush), esophageal candidiasis, and vulvovaginal candidiasis. Cutaneous

Diagnosis relies on clinical assessment supported by laboratory testing. Microscopy with potassium hydroxide preparation, and culture

Treatment depends on the form and severity. Superficial infections are typically treated with topical azoles (eg,

Prevention focuses on addressing risk factors, including judicious antibiotic use, good glycemic control, meticulous care of

candidiasis
affects
moist
skin
areas,
including
diaper
rash
and
intertriginous
folds.
In
immunocompromised
individuals
or
those
with
central
venous
catheters
or
prior
broad-spectrum
antibiotic
exposure,
candidemia
and
invasive
candidiasis
can
occur,
potentially
involving
the
blood,
liver,
spleen,
kidneys,
eyes
or
central
nervous
system.
on
appropriate
media
(often
Sabouraud
dextrose)
are
common.
Species
identification
guides
treatment
choices.
For
suspected
invasive
disease,
blood
cultures
are
important;
nonculture
tests
such
as
β-D-glucan
can
aid
in
assessment
but
are
not
species
specific.
clotrimazole,
miconazole)
or
nystatin;
uncomplicated
vulvovaginal
candidiasis
may
respond
to
a
single
oral
dose
of
fluconazole
or
topical
therapy.
Esophageal
candidiasis
and
invasive
candidiasis
require
systemic
antifungal
therapy,
usually
an
echinocandin
as
initial
treatment,
with
step-down
to
fluconazole
when
susceptible.
Resistance,
particularly
among
C.
glabrata
and
emerging
species
such
as
C.
auris,
is
a
concern
and
influences
therapy.
invasive
devices,
and
prompt
evaluation
of
new
fever
or
sepsis
in
high-risk
patients.